five largest customers
“10-K Item 1: 'In the aggregate, our five largest customers, including CVS Health, accounted for 43 percent of our fiscal 2025 revenue.'”
Updated
The most significant concentration Cardinal Health discloses is five largest customers at 43%, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Cardinal Health’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1: 'In the aggregate, our five largest customers, including CVS Health, accounted for 43 percent of our fiscal 2025 revenue.'”
“10-K Item 1: 'During fiscal 2025, revenue resulting from sales of products obtained from our five largest suppliers accounted for an aggregate of 37 percent of our revenue and our largest supplier’s products accounted for approximately 9 percent of revenue.'”
“10-K Item 1: 'Our largest customer, CVS Health, accounted for 30 percent of our fiscal 2025 revenue.'”
“10-K Item 1: 'Sales to members of these two GPOs, under numerous contracts across our businesses, collectively accounted for 27 percent of our revenue in fiscal 2025.'”
“10-K Item 1: 'During fiscal 2025, revenue resulting from sales of products obtained from our five largest suppliers accounted for an aggregate of 37 percent of our revenue and our largest supplier’s products accounted for approximately 9 percent of revenue.'”
Cardinal Health discloses concentration on both the customer and supplier sides, all of it dependency-type and mostly clustered in the medium-share band. On the customer side, the five largest customers, including CVS Health, accounted for 43% of fiscal 2025 revenue in aggregate, and CVS Health alone — the company's largest customer — accounted for 30% of fiscal 2025 revenue, meaning one customer represents most of that five-customer total. Sales tied to members of the Vizient and Premier group purchasing organizations added a further 27% of revenue across numerous contracts. On the supply side, the five largest suppliers accounted for an aggregate 37% of revenue, though the largest supplier's products alone were only 9% of revenue — a low-share figure suggesting supplier exposure is more distributed than customer exposure. Netting these out, Cardinal Health's more consequential concentration sits with CVS Health and the two large GPOs on the revenue side, since those figures are larger and more counterparty-specific than the supplier book, where even the top supplier represents a comparatively modest share.
For the engine’s reasoning on CAH’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| COR | Cencora, Inc. | 1 | 1 | 1 | 3 |
| CAH● | Cardinal Health, Inc. | 0 | 4 | 1 | 5 |
| HSIC | Henry Schein, Inc. | 0 | 0 | 0 | 0 |
| MCK | McKesson Corporation | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.